サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1534260

アレルギー性鼻炎薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）

Global Allergic Rhinitis Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 225 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アレルギー性鼻炎薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 225 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアレルギー性鼻炎薬の市場規模は、2023年の173億1,000万米ドルから、2032年には229億米ドル近くに達し、調査期間2024年～2032年のCAGRは3.16%と推定されます。

アレルギー性鼻炎薬は、アレルギー反応による鼻粘膜の炎症によって引き起こされる症状を緩和するために設計された薬です。一般に花粉症と呼ばれるアレルギー性鼻炎は、くしゃみ、かゆみ、鼻づまり、涙目などの症状で現れます。これらの薬には主に抗ヒスタミン薬、コルチコステロイド薬、充血除去薬、ロイコトリエン調整薬があり、それぞれアレルギー反応の異なる側面を標的としています。抗ヒスタミン薬はアレルギー反応の主要な媒介物質であるヒスタミンの作用を阻害し、コルチコステロイドは炎症を抑えます。脱血管拡張薬は鼻づまりの解消に役立ち、ロイコトリエン調節薬はアレルギー性炎症の原因となるロイコトリエンの作用を抑制します。これらの薬剤は、経口錠剤、点鼻薬、点眼薬など様々な形態で販売されており、患者の症状の重症度や特定の症状に応じた選択肢を提供しています。

市場力学

都市化、環境汚染、ライフスタイルの変化などの要因により、世界的にアレルギー性鼻炎の有病率が増加しており、治療を必要とする患者層が拡大しています。さらに、医療従事者や患者の意識と診断率の高まりが、アレルギー性鼻炎薬の需要を促進しています。ドラッグデリバリー技術、特に点鼻薬や吸入器の進歩は、治療効果と患者のコンプライアンスを向上させています。これらの技術革新は、患部である鼻組織への薬剤の標的送達を可能にし、それによって症状管理を改善しています。さらに、安全性プロファイルを改善し、効果をより長く持続させる新規製剤の開発に焦点を当てた研究開発が進行中であり、アレルギー性鼻炎薬市場の展望に革命をもたらす態勢を整えています。さらに、製薬企業と医療提供者との戦略的提携やパートナーシップは、市場の拡大を促進します。これらの提携は、革新的な治療法の開拓を促進し、マーケティング努力の結集と流通チャネルの強化を通じて市場浸透を向上させます。しかし、アレルギー性鼻炎薬市場は、一般用医薬品（OTC）の利用可能性やジェネリック医薬品の競合といった課題に直面しています。OTC抗ヒスタミン薬や点鼻薬が広く普及していることや、コスト意識の高い消費者がジェネリック医薬品を選ぶことが、このセグメントにおけるブランド医薬品の市場成長を大幅に抑制しています。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはアレルギー性鼻炎薬の世界市場における各セグメントを包括的に評価することもできます。アレルギー性鼻炎薬業界の成長と動向は、この調査への全体的なアプローチを提供します。

市場セグメンテーション

アレルギー性鼻炎薬市場レポートでは、国別および地域別のセグメントに関する詳細なデータを提供することで、戦略担当者がそれぞれの製品またはサービスのターゲット層を特定し、今後のビジネスチャンスに役立てることができます。

地域別分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの地域展望をカバーし、アレルギー性鼻炎薬市場の現在と将来の需要を明らかにしています。さらに、すべての主要地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 アレルギー性鼻炎薬- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 アレルギー性鼻炎薬の世界市場分析：疾患別

  • 疾患別の概要
  • 疾患別の実績・予測データ分析
  • 季節性アレルギー性鼻炎
  • 通年性アレルギー性鼻炎
  • 職業性アレルギー性鼻炎

第6章 アレルギー性鼻炎薬の世界市場分析：治療別

  • 治療別の概要
  • 治療別の実績・予測データ分析
  • 抗ヒスタミン薬
  • 免疫療法（SCIT、SLIT）
  • 副腎皮質ステロイド薬
  • うっ血除去薬
  • その他

第7章 アレルギー性鼻炎薬の世界市場分析：薬剤別

  • 薬剤別の概要
  • 薬剤別の実績・予測データ分析
  • 処方薬
  • 一般用医薬品

第8章 アレルギー性鼻炎薬の世界市場分析：投与経路別

  • 投与経路別の概要
  • 投与経路別の実績・予測データ分析
  • 経口
  • 経鼻
  • 眼内
  • 静脈内

第9章 アレルギー性鼻炎薬の世界市場分析：流通チャネル別

  • 流通チャネル別の概要
  • 流通チャネル別の実績・予測データ分析
  • 小売薬局
  • 院内薬局
  • オンラインチャネル

第10章 アレルギー性鼻炎薬の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第11章 アレルギー性鼻炎薬企業の競合情勢

  • アレルギー性鼻炎薬の市場競争
  • 提携・協力・協定
  • 合併・買収
  • 新製品の上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Teva Pharmaceutical Industries Lt
  • Boehringer Ingelheim
  • Unichem Laboratories
  • Stallergenes Greer
  • Sanofi S.A.
  • Alcon（Novartis AG）
  • Johnson & Johnson
  • Meda AB
  • Mylan NV
  • Allergy Therapeutics PLC
  • ALK-Abell6 A/S
  • Glenmark Pharmaceuticals Ltd
  • Bayer AG
  • Dr. Reddy'S Laboratories
  • Adamis Pharmaceuticals
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease (USD MN)
  • Seasonal Allergic Rhinitis Market Sales By Geography (USD MN)
  • Perennial Allergic Rhinitis Market Sales By Geography (USD MN)
  • Occupational Allergic Rhinitis Market Sales By Geography (USD MN)
  • Analysis By Treatment (USD MN)
  • Antihistamines Market Sales By Geography (USD MN)
  • Immunotherapy (SCIT, SLIT) Market Sales By Geography (USD MN)
  • Corticosteroids Market Sales By Geography (USD MN)
  • Decongestants Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Drug (USD MN)
  • Prescription Market Sales By Geography (USD MN)
  • OTC Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Intraocular Market Sales By Geography (USD MN)
  • Intravenous Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Online Channel Market Sales By Geography (USD MN)
  • Global Allergic Rhinitis Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Allergic Rhinitis Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Allergic Rhinitis Drugs Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease
  • Market Attractiveness Analysis By Treatment
  • Market Attractiveness Analysis By Drug
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease (USD MN)
  • Seasonal Allergic Rhinitis Market Sales By Geography (USD MN)
  • Perennial Allergic Rhinitis Market Sales By Geography (USD MN)
  • Occupational Allergic Rhinitis Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment (USD MN)
  • Antihistamines Market Sales By Geography (USD MN)
  • Immunotherapy (SCIT, SLIT) Market Sales By Geography (USD MN)
  • Corticosteroids Market Sales By Geography (USD MN)
  • Decongestants Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug (USD MN)
  • Prescription Market Sales By Geography (USD MN)
  • OTC Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Nasal Market Sales By Geography (USD MN)
  • Intraocular Market Sales By Geography (USD MN)
  • Intravenous Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Online Channel Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112115272

The global demand for Allergic Rhinitis Drugs Market is presumed to reach the market size of nearly USD 22.9 Billion by 2032 from USD 17.31 Billion in 2023 with a CAGR of 3.16% under the study period 2024-2032.

Allergic rhinitis drugs are medications designed to alleviate symptoms caused by inflammation of the nasal mucous membranes due to allergic reactions. Commonly called hay fever, allergic rhinitis manifests through symptoms such as sneezing, itching, nasal congestion, and watery eyes. These drugs primarily include antihistamines, corticosteroids, decongestants, and leukotriene modifiers, each targeting different aspects of the allergic response. Antihistamines block the action of histamine, a key mediator of allergic reactions, while corticosteroids reduce inflammation. Decongestants help relieve nasal congestion, and leukotriene modifiers inhibit the effects of leukotrienes, which contribute to allergic inflammation. These medications are available in various forms, including oral tablets, nasal sprays, and eye drops, offering patients options based on their condition's severity and specific symptoms.

MARKET DYNAMICS

The increasing prevalence of allergic rhinitis globally, attributed to factors such as urbanization, environmental pollution, and changing lifestyles, is expanding the patient pool requiring treatment. Moreover, heightened awareness and diagnosis rates among healthcare professionals and patients are driving demand for allergic rhinitis drugs. Advancements in drug delivery technologies, particularly in nasal sprays and inhalers, are enhancing treatment efficacy and patient compliance. These innovations enable targeted delivery of medications to affected nasal tissues, thereby improving symptom management. Additionally, ongoing research & development activities focused on developing novel formulations with improved safety profiles and longer-lasting effects are poised to revolutionize the allergic rhinitis drugs market landscape. Furthermore, strategic collaborations and partnerships between pharmaceutical companies and healthcare providers facilitate market expansion. These alliances foster the development of innovative therapies and improve market penetration through combined marketing efforts and enhanced distribution channels. However, the allergic rhinitis drugs market faces challenges such as the availability of over-the-counter (OTC) alternatives and generic competition. The widespread availability of OTC antihistamines and nasal sprays and cost-conscious consumers opting for generic medications significantly restrain market growth for branded pharmaceuticals in this segment.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Allergic Rhinitis Drugs. The growth and trends of Allergic Rhinitis Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Allergic Rhinitis Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease

  • Seasonal Allergic Rhinitis
  • Perennial Allergic Rhinitis
  • Occupational Allergic Rhinitis

By Treatment

  • Antihistamines
  • Immunotherapy (SCIT, SLIT)
  • Corticosteroids
  • Decongestants
  • Others

By Drug

  • Prescription
  • OTC

By Route of Administration

  • Oral
  • Nasal
  • Intraocular
  • Intravenous

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Channel

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Allergic Rhinitis Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Allergic Rhinitis Drugs market include Teva Pharmaceutical Industries Lt, Boehringer Ingelheim, Unichem Laboratories, Stallergenes Greer, Sanofi S.A., Alcon (Novartis AG), Johnson & Johnson, Meda AB, Mylan NV, Allergy Therapeutics PLC, ALK-Abell6 A/S, Glenmark Pharmaceuticals Ltd, Bayer AG, Dr. Reddy'S Laboratories, Adamis Pharmaceuticals, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ALLERGIC RHINITIS DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease
    • 3.7.2 Market Attractiveness Analysis By Treatment
    • 3.7.3 Market Attractiveness Analysis By Drug
    • 3.7.4 Market Attractiveness Analysis By Route of Administration
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ALLERGIC RHINITIS DRUGS MARKET ANALYSIS BY DISEASE

  • 5.1. Overview By Disease
  • 5.2. Historical and Forecast Data Analysis By Disease
  • 5.3. Seasonal Allergic Rhinitis Historic and Forecast Sales By Regions
  • 5.4. Perennial Allergic Rhinitis Historic and Forecast Sales By Regions
  • 5.5. Occupational Allergic Rhinitis Historic and Forecast Sales By Regions

6. GLOBAL ALLERGIC RHINITIS DRUGS MARKET ANALYSIS BY TREATMENT

  • 6.1. Overview By Treatment
  • 6.2. Historical and Forecast Data Analysis By Treatment
  • 6.3. Antihistamines Historic and Forecast Sales By Regions
  • 6.4. Immunotherapy (SCIT, SLIT) Historic and Forecast Sales By Regions
  • 6.5. Corticosteroids Historic and Forecast Sales By Regions
  • 6.6. Decongestants Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL ALLERGIC RHINITIS DRUGS MARKET ANALYSIS BY DRUG

  • 7.1. Overview By Drug
  • 7.2. Historical and Forecast Data Analysis By Drug
  • 7.3. Prescription Historic and Forecast Sales By Regions
  • 7.4. OTC Historic and Forecast Sales By Regions

8. GLOBAL ALLERGIC RHINITIS DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 8.1. Overview By Route of Administration
  • 8.2. Historical and Forecast Data Analysis By Route of Administration
  • 8.3. Oral Historic and Forecast Sales By Regions
  • 8.4. Nasal Historic and Forecast Sales By Regions
  • 8.5. Intraocular Historic and Forecast Sales By Regions
  • 8.6. Intravenous Historic and Forecast Sales By Regions

9. GLOBAL ALLERGIC RHINITIS DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1. Overview By Distribution Channel
  • 9.2. Historical and Forecast Data Analysis By Distribution Channel
  • 9.3. Retail Pharmacies Historic and Forecast Sales By Regions
  • 9.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 9.5. Online Channel Historic and Forecast Sales By Regions

10. GLOBAL ALLERGIC RHINITIS DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE ALLERGIC RHINITIS DRUGS COMPANIES

  • 11.1. Allergic Rhinitis Drugs Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF ALLERGIC RHINITIS DRUGS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Teva Pharmaceutical Industries Lt
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Boehringer Ingelheim
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Unichem Laboratories
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Stallergenes Greer
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Sanofi S.A.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Alcon (Novartis AG)
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Johnson & Johnson
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Meda AB
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Mylan NV
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Allergy Therapeutics PLC
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. ALK-Abell6 A/S
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. Glenmark Pharmaceuticals Ltd
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments
  • 12.15. Bayer AG
    • 12.15.1 Company Overview
    • 12.15.2 Company Revenue
    • 12.15.3 Products
    • 12.15.4 Recent Developments
  • 12.16. Dr. Reddy'S Laboratories
    • 12.16.1 Company Overview
    • 12.16.2 Company Revenue
    • 12.16.3 Products
    • 12.16.4 Recent Developments
  • 12.17. Adamis Pharmaceuticals
    • 12.17.1 Company Overview
    • 12.17.2 Company Revenue
    • 12.17.3 Products
    • 12.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies